C. Haie-meder, R. Pötter, E. Van-limbergen, E. Briot, D. Brabandere et al., Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group??? (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV, Radiotherapy and Oncology, vol.74, issue.3, pp.235-280, 2005.
DOI : 10.1016/j.radonc.2004.12.015

K. Han, M. Milosevic, A. Fyles, M. Pintilie, and A. Viswanathan, Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States, International Journal of Radiation Oncology*Biology*Physics, vol.87, issue.1, pp.111-120, 2013.
DOI : 10.1016/j.ijrobp.2013.05.033

C. Hennequin and J. Mazeron, Radiobiologie de la curieth??rapie, Cancer/Radioth??rapie, vol.17, issue.2, pp.81-85
DOI : 10.1016/j.canrad.2013.03.001

P. Swift, P. Purser, L. Roberts, B. Pickett, C. Powell et al., Pulsed low dose rate brachytherapy for pelvic malignancies, International Journal of Radiation Oncology*Biology*Physics, vol.37, issue.4, pp.811-818, 1997.
DOI : 10.1016/S0360-3016(96)00564-0

C. Rogers, J. Freel, and B. Speiser, Pulsed low dose rate brachytherapy for uterine cervix carcinoma, International Journal of Radiation Oncology*Biology*Physics, vol.43, issue.1, pp.95-100, 1999.
DOI : 10.1016/S0360-3016(98)00367-8

B. Bachtiary, A. Dewitt, M. Pintilie, J. Jezioranski, S. Ahonen et al., Comparison of late toxicity between continuous low-dose-rate and pulsed-dose-rate brachytherapy in cervical cancer patients, International Journal of Radiation Oncology*Biology*Physics, vol.63, issue.4, pp.1077-82, 2005.
DOI : 10.1016/j.ijrobp.2005.04.040

C. Chargari, N. Magné, I. Dumas, T. Messai, L. Vicenzi et al., Physics Contributions and Clinical Outcome With 3D-MRI???Based Pulsed-Dose-Rate Intracavitary Brachytherapy in Cervical Cancer Patients, International Journal of Radiation Oncology*Biology*Physics, vol.74, issue.1, pp.133-142, 2009.
DOI : 10.1016/j.ijrobp.2008.06.1912

G. Rath, D. Sharma, P. Julka, V. Subramani, A. Bahl et al., Pulsed-doserate intracavitary brachytherapy for cervical carcinoma: the AIIMS experience, Am J Clin Oncol, vol.33, issue.3, pp.238-279, 2010.

I. Jürgenliemk-schulz, S. Lang, K. Tanderup, A. De-leeuw, C. Kirisits et al., Variation of treatment planning parameters (D90 HR-CTV, D2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: Comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose???volume constraints, Radiotherapy and Oncology, vol.94, issue.3, pp.339-384, 2010.
DOI : 10.1016/j.radonc.2009.10.011

M. Levitchi, C. Charra-brunaud, P. Quetin, C. Haie-meder, C. Kerr et al., Impact of dosimetric and clinical parameters on clinical side effects in cervix cancer patients treated with 3D pulse-dose-rate intracavitary brachytherapy, Radiotherapy and Oncology, vol.103, issue.3
DOI : 10.1016/j.radonc.2012.04.008

R. Oncol, J. Eur-soc-ther-radiol-oncol-charra-brunaud, C. Harter, V. Delannes, M. Haie-meder et al., Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study, pp.314-335, 2012.

M. De-brabandere, A. Mousa, A. Nulens, A. Swinnen, and E. Van-limbergen, Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma, Radiotherapy and Oncology, vol.88, issue.2, pp.217-243, 2008.
DOI : 10.1016/j.radonc.2007.10.026

J. Lindegaard, K. Tanderup, S. Nielsen, S. Haack, and J. Gelineck, MRI-Guided 3D Optimization Significantly Improves DVH Parameters of Pulsed-Dose-Rate Brachytherapy in Locally Advanced Cervical Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.71, issue.3, pp.756-64, 2008.
DOI : 10.1016/j.ijrobp.2007.10.032

K. Tanderup, R. Pötter, J. Lindegaard, D. Berger, A. Wambersie et al., PTV margins should not be used to compensate for uncertainties in 3D image guided intracavitary brachytherapy, Radiotherapy and Oncology, vol.97, issue.3, 2010.
DOI : 10.1016/j.radonc.2010.08.021

I. Barillot, J. Horiot, P. Maingon, G. Truc, G. Chaplain et al., Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: baseline results to compare new strategies, International Journal of Radiation Oncology*Biology*Physics, vol.48, issue.1, pp.189-200, 2000.
DOI : 10.1016/S0360-3016(00)00556-3

S. Chen, J. Liang, S. Yang, R. Liu, and F. Lin, The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy, International Journal of Radiation Oncology*Biology*Physics, vol.47, issue.4, pp.955-61, 2000.
DOI : 10.1016/S0360-3016(00)00559-9

P. Eifel, W. Thoms, . Jr, T. Smith, M. Morris et al., The relationship between brachytherapy dose and outcome in patients with bulky endocervical tumors treated with radiation alone, International Journal of Radiation Oncology*Biology*Physics, vol.28, issue.1, pp.113-121, 1994.
DOI : 10.1016/0360-3016(94)90148-1

P. Eifel and H. Thames, Has the influence of treatment duration on local control of carcinoma of the cervix been defined?, International Journal of Radiation Oncology*Biology*Physics, vol.32, issue.5, pp.1527-1536, 1995.
DOI : 10.1016/0360-3016(95)00264-Y

H. Kim, T. Choi, J. Park, S. Lee, S. Lee et al., Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma. Cancer, pp.1304-1315, 2005.

C. Perez, P. Grigsby, M. Lockett, K. Chao, and J. Williamson, Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation, International Journal of Radiation Oncology*Biology*Physics, vol.44, issue.4, pp.855-66, 1999.
DOI : 10.1016/S0360-3016(99)00111-X

K. Sakata, H. Nagakura, A. Oouchi, M. Someya, K. Nakata et al., High-dose-rate intracavitary brachytherapy: results of analyses of late rectal complications, International Journal of Radiation Oncology*Biology*Physics, vol.54, issue.5, pp.1369-76, 2002.
DOI : 10.1016/S0360-3016(02)03055-9

P. Georg, C. Kirisits, G. Goldner, W. Dörr, J. Hammer et al., Correlation of dose???volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy, Radiotherapy and Oncology, vol.91, issue.2, 2009.
DOI : 10.1016/j.radonc.2009.01.006

B. Clark, L. Souhami, T. Roman, R. Chappell, M. Evans et al., The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix, International Journal of Radiation Oncology*Biology*Physics, vol.38, issue.5, pp.989-93, 1997.
DOI : 10.1016/S0360-3016(97)00074-6

W. Koom, D. Sohn, J. Kim, J. Kim, K. Shin et al., Computed Tomography-Based High-Dose-Rate Intracavitary Brachytherapy for Uterine Cervical Cancer: Preliminary Demonstration of Correlation Between Dose???Volume Parameters and Rectal Mucosal Changes Observed by Flexible Sigmoidoscopy, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.5, pp.1446-54, 2007.
DOI : 10.1016/j.ijrobp.2007.02.009

R. Pötter, J. Dimopoulos, B. Bachtiary, G. Sissolak, B. Klos et al., 3D conformal HDR-brachy- and external beam therapy plus simultaneous Cisplatin for high-risk cervical cancer: Clinical experience with 3 year follow-up, Radiotherapy and Oncology, vol.79, issue.1
DOI : 10.1016/j.radonc.2006.01.007

H. Kang, K. Shin, S. Park, J. Kim, E. Fidarova et al., 3D CT-based high-dose-rate brachytherapy for cervical cancer: clinical impact on late rectal bleeding and local control Dose volume parameter D2cc does not correlate with vaginal side effects in individual patients with cervical cancer treated within a defined treatment protocol with very high brachytherapy doses Charra-Brunaud C, Peiffert D. [Preliminary results of a French prospectivemulticentric study of 3D pulsed dose-rate brachytherapy for cervix carcinoma]. Cancer Radiothérapie J Société Française Radiothérapie Oncol, Radiother Oncol J Eur Soc Ther Radiol Oncol Radiother Oncol J Eur Soc Ther Radiol Oncol, vol.979712, issue.29, pp.507-520, 2008.

N. Magné, C. Chargari, L. Vicenzi, N. Gillion, T. Messai et al., New trends in the evaluation and treatment of cervix cancer: The role of FDG???PET, Cancer Treatment Reviews, vol.34, issue.8, pp.671-81, 2008.
DOI : 10.1016/j.ctrv.2008.08.003

D. Groheux, J. Moretti, S. Giacchetti, E. Hindié, P. Teyton et al., PET/CT in breast cancer: an update], Bull Cancer, 2009.

K. Lim, W. Small, . Jr, L. Portelance, C. Creutzberg et al., Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiotherapy for the Definitive Treatment of Cervix Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.79, issue.2, pp.348-55, 2011.
DOI : 10.1016/j.ijrobp.2009.10.075

R. Dinniwell, P. Chan, G. Czarnota, M. Haider, K. Jhaveri et al., Pelvic Lymph Node Topography for Radiotherapy Treatment Planning From Ferumoxtran-10 Contrast-Enhanced Magnetic Resonance Imaging, CL 3rd, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma, pp.844-51, 1999.
DOI : 10.1016/j.ijrobp.2008.09.026

R. Nath, L. Anderson, G. Luxton, K. Weaver, J. Williamson et al., (cisplatin and 5- fluorouracil) for advanced or recurrent gynecologic malignancies. Preliminary report Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43, Phase I/II study of definitive radiotherapy and chemotherapy, pp.467-73, 1989.

T. M. and M. Wj, Treatment of cancer of the cervix uteri, a revised Manchester method, Br J Radiol, vol.26, issue.305, pp.252-259, 1953.

B. Shwetha, M. Ravikumar, A. Katke, S. Supe, G. Venkatagiri et al., Dosimetric comparison of various optimization techniques for high dose rate brachytherapy of interstitial cervix implants Five classes of extended hysterectomy for women with cervical cancer Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours, J Appl Clin Med Phys Am Coll Med Phys. Obstet Gynecol. Int J Radiat Oncol Biol Phys, vol.114468, issue.322, pp.265-72, 1974.

C. Kirisits, R. Pötter, S. Lang, J. Dimopoulos, N. Wachter-gerstner et al., Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer, International Journal of Radiation Oncology*Biology*Physics, vol.62, issue.3, pp.901-912, 2005.
DOI : 10.1016/j.ijrobp.2005.02.040

D. Chassagne, A. Gerbaulet, and J. Cosset, Diagnostic value of vaginal mouldings in uterine cancer (author's transl)], J Radiol, vol.60, issue.5, pp.371-374, 1979.

C. Haie-meder, C. Chargari, A. Rey, I. Dumas, P. Morice et al., MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy Posttherapy surveillance of women with cervical cancer: an outcomes analysis Comparison of dose-volume histograms and dose-wall histograms of the rectum of patients treated with intracavitary brachytherapy Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point, Radiother Oncol J Eur Soc Ther Radiol Oncol. Gynecol Oncol. Olszewska AM Radiother Oncol J Eur Soc Ther Radiol Oncol. Radiother Oncol J Eur Soc Ther Radiol Oncol, vol.967861, issue.46, pp.161-5187, 2000.

C. Chargari, I. Fromantin, and Y. Kirova, Importance of local skin treatments during radiotherapy for prevention and treatment of radio-induced epithelitis], Cancer Radiothérapie J Société Française Radiothérapie Oncol, 2009.

J. Green, J. Kirwan, J. Tierney, P. Symonds, L. Fresco et al., Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis, Lancet, 2001.

R. Pötter, P. Georg, J. Dimopoulos, M. Grimm, D. Berger et al., Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer, Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group, pp.116-139, 2011.
DOI : 10.1016/j.radonc.2011.07.012

P. Lèguevaque, S. Motton, M. Delannes, D. Querleu, M. Soulé-tholy et al., Completion surgery or not after concurrent chemoradiotherapy for locally advanced cervical cancer?, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.155, issue.2, 2011.
DOI : 10.1016/j.ejogrb.2010.11.016

C. Perez and M. Kao, Radiation therapy alone or combined with surgery in the treatment of barrel-shaped carcinoma of the uterine cervix (stages IB, IIA, IIB), International Journal of Radiation Oncology*Biology*Physics, vol.11, issue.11, pp.1903-1912, 1985.
DOI : 10.1016/0360-3016(85)90270-6

C. Touboul, C. Uzan, A. Mauguen, S. Gouy, A. Rey et al., Survival and prognostic factors after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer]. Gynécologie Obstétrique Fertil, pp.274-80, 2011.

P. Grigsby, The prognostic value of PET and PET/CT in cervical cancer, Cancer Imaging, vol.8, issue.1, pp.146-55, 2008.
DOI : 10.1102/1470-7330.2008.0022